First Comprehensive Report of Clinicopathological Profile of Breast Cancer from Bihar, India
Tóm tắt
Only a few countries of the world have a population more than Bihar, but due to the lack of a cancer registry, authentic research, and publications, data regarding the clinicopathological characteristics of breast cancer patients from this state are scarce. The present study was aimed to report the clinicopathological characteristics of breast cancer patients at a tertiary care center in Bihar, India. This is a retrospective review of a prospectively maintained database of patients of breast cancer treated between January-2018 and March-2020. One hundred fifteen patients with breast carcinoma were included of which 112 (97.4%) were women. The mean age was 47.28 ± 11.62 years and 54.5% of women were postmenopausal. Most patients had a clinical stage of II or III (44.5% each) while 8.7% of patients had stage IV disease. Invasive ductal carcinoma no special type (IDC-NST) was the most common histology (85.2%). The majority of tumors were grade II (55.6%), lymphovascular invasion was seen in 45.6%, and perineural invasion in 18.4%. Estrogen receptor was found in 41.8%, progesterone receptor was positive in 47.3%, and human epidermal growth factor receptor-2 (HER-2/Neu) overexpression was observed in 39.8%. Triple-negative breast cancer was found in 26.2% of patients. The majority underwent mastectomy (71.3%) while breast conservation was done in 26%. All except one patient underwent axillary lymph node dissection for axillary staging. 43.5% patients received neoadjuvant chemotherapy, 52.9% received adjuvant chemotherapy, while 3.5% patients received palliative chemotherapy. The clinicopathological profile of breast cancer patients from Bihar is similar to that reported from other parts of India except for a lower rate of distant metastasis.
Tài liệu tham khảo
Rangarajan B, Shet T, Wadasadawala T, Nair NS, Sairam RM, Hingmire SS, Bajpai J (2016) Breast cancer: an overview of published Indian data. South Asian J Cancer 5(3):86–92. https://doi.org/10.4103/2278-330X.187561
Nene BM, Selmouni F, Lokhande M, Hingmire SJ, Muwonge R, Jayant K, Sankaranarayanan R (2018) Patterns of care of breast cancer patients in a rural cancer center in Western India. Indian J Surg Oncol 9(3):374–380. https://doi.org/10.1007/s13193-018-0748-4
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, Global cancer statistics (2018) GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Three-Year Report of Population Based Cancer Registries 2012–2014. https://ncdirindia.org/ncrp/Annual_Reports.aspx. Accessed 26 May 2021
Suhani S, Kazi M, Parshad R, Seenu V, Verma E, Mathur S, Gupta SD, Haresh KP (2020) An audit of over 1000 breast cancer patients from a tertiary care center of Northern India. Breast Dis 39(2):91–99. https://doi.org/10.3233/BD-190435
Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42(1):40–5. https://doi.org/10.4103/0019-509x.15099
Executive Summary- Census of India 2011. https://censusindia.gov.in/2011-prov-results/paper2/data_files/Bihar/4-ex-summery.pdf. Accessed 26 May 2021
Pandey A, Raj S, Madhawi R, Devi S, Singh RK (2019) Cancer trends in Eastern India: retrospective hospital-based cancer registry data analysis. South Asian J Cancer 8(4):215–217. https://doi.org/10.4103/sajc.sajc_321_18
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010
Mathew A, Pandey M, Rajan B (2004) Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis? World J Surg Oncol 22(2):2. https://doi.org/10.1186/1477-7819-2-2
Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134–147. https://doi.org/10.1002/cncr.11051
Gogia A, Deo SV, Shukla NK, Mathur S, Sharma DN, Tiwari A (2018) Clinicopathological profile of breast cancer: an institutional experience. Indian J Cancer 55(3):210–213. https://doi.org/10.4103/ijc.IJC_73_18
Nair N, Shet T, Parmar V, Havaldar R, Gupta S, Budrukkar A et al (2018) Breast cancer in a tertiary cancer center in India - an audit, with outcome analysis. Indian J Cancer 55(1):16–22. https://doi.org/10.4103/ijc.IJC_484_17
Camacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC et al (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109(11):2190–2196. https://doi.org/10.1002/cncr.22672
Garg PK, Deo SV, Kumar R, Shukla NK, Thulkar S, Gogia A et al (2016) Staging PET-CT scanning provides superior detection of lymph nodes and distant metastases than traditional imaging in locally advanced breast cancer. World J Surg 40(8):2036–2042. https://doi.org/10.1007/s00268-016-3570-6
Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G (2021) In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study. Breast Cancer Res 23(1):17. https://doi.org/10.1186/s13058-021-01393-z
Samman S, Cornacchi SD, Foster G, Thabane L, Thomson S, Lovrics O, Martin S, Lovrics PJ (2020) A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer. Am J Surg. 2021 Aug;222(2):361–367. https://doi.org/10.1016/j.amjsurg. 12.029. Epub 2020 Dec 25.
Jha CK, Mishra A, Yadav SB, Agarwal G, Singh S, Chand G, Agarwal A, Mishra SK. Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study. Arch Endocrinol Metab. 2021 May 18;64(6):743–750. https://doi.org/10.20945/2359-3997000000284.
Augustine P, Ramesh SA, Nair RK, Sukumaran R, Jose R, Cherian K, Muralee M, Ahamad I. Nipple Areola Complex Involvement in Invasive Carcinoma Breast. Indian J Surg Oncol. 2018 Sep;9(3):343–348. https://doi.org/10.1007/s13193-018-0729-7. Epub 2018 Feb 8.
Singh D, Mandal A (2020) The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients. Breast Cancer Res Treat 184(3):839–848. https://doi.org/10.1007/s10549-020-05885-y
Doval DC, Radhakrishna S, Tripathi R, Kashinath RI, Talwar V, Batra U et al (2020) A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery. Sci Rep 10(1):5886. https://doi.org/10.1038/s41598-020-62618-3
Dutta V, Chopra GS, Sahai K, Nema SK (2008) Hormone receptors, Her-2/Neu and chromosomal aberrations in breast cancer. Med J Armed Forces India 64(1):11–5. https://doi.org/10.1016/S0377-1237(08)80137-2
Hassan Ali S, Somashekhar SP, Arun Kumar N (2019) Rate of breast-conserving surgery vs mastectomy in breast cancer: a tertiary care centre experience from South India. Indian J Surg Oncol 10(1):72–76. https://doi.org/10.1007/s13193-018-0818-7
Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010) Profile of breast cancer patients at a tertiary care hospital in north India. Indian J Cancer 47(1):16–22. https://doi.org/10.4103/0019-509X.58853